SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Sai Krishna J. Munjampalli, Debra E. Davis, Medicinal-Induced Behavior Disorders, Neurologic Clinics, 2016, 34, 1, 133

    CrossRef

  2. 2
    E. Trinka, B. J. Steinhoff, M. Nikanorova, M. J. Brodie, Perampanel for focal epilepsy: insights from early clinical experience, Acta Neurologica Scandinavica, 2016, 133, 3
  3. 3
    O. Bonnot, D. Cohen, D. Thuilleaux, A. Consoli, S. Cabal, M. Tauber, Psychotropic treatments in Prader-Willi syndrome: a critical review of published literature, European Journal of Pediatrics, 2016, 175, 1, 9

    CrossRef

  4. 4
    Christian Brandt, Denise Lahr, Theodor W. May, Cognitive adverse events of topiramate in patients with epilepsy and intellectual disability, Epilepsy & Behavior, 2015, 45, 261

    CrossRef

  5. 5
    Marte Helene Bjørk, Gyri Veiby, Simone C. Reiter, Jan Øystein Berle, Anne Kjersti Daltveit, Olav Spigset, Bernt A. Engelsen, Nils Erik Gilhus, Depression and anxiety in women with epilepsy during pregnancy and after delivery: A prospective population-based cohort study on frequency, risk factors, medication, and prognosis, Epilepsia, 2015, 56, 1
  6. 6
    Terri S. Armstrong, Robin Grant, Mark R. Gilbert, Jong Woo Lee, Andrew D. Norden, Epilepsy in glioma patients: mechanisms, management, and impact of anticonvulsant therapy: Table 1., Neuro-Oncology, 2015, nov269

    CrossRef

  7. 7
    Ivan Rektor, Steven C. Schachter, Ravindra Arya, Shahar Arzy, Hilde Braakman, Martin J. Brodie, Peter Brugger, Bernard S. Chang, Alla Guekht, Bruce Hermann, Dale C. Hesdorffer, Marilyn Jones-Gotman, Andres M. Kanner, Luis Garcia-Larrea, Pavel Mareš, Marco Mula, Miri Neufeld, Gail L. Risse, Philippe Ryvlin, Margitta Seeck, Torbjörn Tomson, Amos D. Korczyn, Third International Congress on Epilepsy, Brain, and Mind: Part 2, Epilepsy & Behavior, 2015, 50, 138

    CrossRef

  8. 8
    Juan Manuel Orjuela-Rojas, Iris E. Martínez-Juárez, Angel Ruiz-Chow, Daniel Crail-Melendez, Treatment of depression in patients with temporal lobe epilepsy: A pilot study of cognitive behavioral therapy vs. selective serotonin reuptake inhibitors, Epilepsy & Behavior, 2015, 51, 176

    CrossRef

  9. 9
    Meiyan Yang, Si Xie, Qiu Li, Yuli Wang, Xinyi Chang, Li Shan, Lei Sun, Xiaoli Huang, Chunsheng Gao, Effects of polyvinylpyrrolidone both as a binder and pore-former on the release of sparingly water-soluble topiramate from ethylcellulose coated pellets, International Journal of Pharmaceutics, 2014, 465, 1-2, 187

    CrossRef

  10. 10
    Jay A. Salpekar, Gaurav Mishra, Key Issues in Addressing the Comorbidity of Attention Deficit Hyperactivity Disorder and Pediatric Epilepsy, Epilepsy & Behavior, 2014, 37, 310

    CrossRef

  11. 11
    Andres M. Kanner, Lennox-Lombroso Lecture, 2013: Psychiatric Comorbidities Through the Life of the Seizure Disorder: A Complex Relation With a Not So Complex Solution, Epilepsy Currents, 2014, 14, 6, 323

    CrossRef

  12. 12
    Maurice J Clancy, Mary C Clarke, Dearbhla J Connor, Mary Cannon, David R Cotter, The prevalence of psychosis in epilepsy; a systematic review and meta-analysis, BMC Psychiatry, 2014, 14, 1, 75

    CrossRef

  13. 13
    Piero Perucca, Marco Mula, Antiepileptic drug effects on mood and behavior: Molecular targets, Epilepsy & Behavior, 2013, 26, 3, 440

    CrossRef

  14. 14
    Marco Mula, Andres M. Kanner, Bettina Schmitz, Steven Schachter, Antiepileptic drugs and suicidality: An expert consensus statement from the Task Force on Therapeutic Strategies of the ILAE Commission on Neuropsychobiology, Epilepsia, 2013, 54, 1
  15. 15
    Eszter Kirilly, Xénia Gonda, Gabriella Juhász, György Bagdy, Anxiogenic and depressogenic side-effects of non-psychiatric drugs, Orvosi Hetilap, 2013, 154, 34, 1327

    CrossRef

  16. 16
    Yoko Ohtsuka, Efficacy Confirmatory Study of Topiramate in Children with Symptomatic or Cryptogenic Localization-related Epilepsy, Journal of the Japan Epilepsy Society, 2013, 31, 1, 19

    CrossRef

  17. 17
    Amos D. Korczyn, Steven C. Schachter, Martin J. Brodie, Sarang S. Dalal, Jerome Engel, Alla Guekht, Hrvoje Hecimovic, Karim Jerbi, Andres M. Kanner, Cecilie Johannessen Landmark, Pavel Mares, Petr Marusic, Stefano Meletti, Marco Mula, Philip N. Patsalos, Markus Reuber, Philippe Ryvlin, Klára Štillová, Roberto Tuchman, Ivan Rektor, Epilepsy, cognition, and neuropsychiatry (Epilepsy, Brain, and Mind, part 2), Epilepsy & Behavior, 2013, 28, 2, 283

    CrossRef

  18. 18
    Minfeng Cheng, Shenglin Wen, Xiumei Tang, Zhiyong Zhong, Hallucinations and comorbid renal tubular acidosis caused by topiramate in a patient with psychiatric history, General Hospital Psychiatry, 2013, 35, 2, 213.e1

    CrossRef

  19. 19
    A. Labate, L. Mumoli, A. Fratto, A. Quattrone, A. Gambardella, Hippocampal sclerosis worsens autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) phenotype related to CHRNB2 mutation, European Journal of Neurology, 2013, 20, 3
  20. 20
    Marco Mula, Investigating psychotropic properties of antiepileptic drugs, Expert Review of Neurotherapeutics, 2013, 13, 6, 639

    CrossRef

  21. 21
    Marco Mula, Josemir W Sander, Suicide risk in people with epilepsy taking antiepileptic drugs, Bipolar Disorders, 2013, 15, 5
  22. 22
    B. de Toffol, Troubles psychiatriques de l’épilepsie chez l’adulte, EMC - Psychiatrie, 2013, 10, 1, 1

    CrossRef

  23. 23
    David Taylor, Frank Besag, Pediatric Neurology Part I, 2013,

    CrossRef

  24. 24
    Piero Perucca, Frank G Gilliam, Adverse effects of antiepileptic drugs, The Lancet Neurology, 2012, 11, 9, 792

    CrossRef

  25. 25
    John Piedad, Hugh Rickards, Frank M.C. Besag, Andrea E. Cavanna, Beneficial and Adverse Psychotropic Effects of Antiepileptic Drugs in Patients with Epilepsy, CNS Drugs, 2012, 26, 4, 319

    CrossRef

  26. 26
    Takahiro Noguchi, Naofumi Fukatsu, Hiroko Kato, Tomohiro Oshima, Kousuke Kanemoto, Impact of antiepileptic drugs on genesis of psychosis, Epilepsy & Behavior, 2012, 23, 4, 462

    CrossRef

  27. 27
    Stefano Comai, Michael Tau, Zoran Pavlovic, Gabriella Gobbi, The Psychopharmacology of Aggressive Behavior, Journal of Clinical Psychopharmacology, 2012, 32, 2, 237

    CrossRef

  28. 28
    Alkomiet Hasan, Peter Falkai, Thomas Wobrock, Jeffrey Lieberman, Birte Glenthoj, Wagner F. Gattaz, Florence Thibaut, Hans-Jürgen Möller, World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance, The World Journal of Biological Psychiatry, 2012, 13, 5, 318

    CrossRef

  29. 29
    Andres M. Kanner, Dale C. Hesdorffer, Epilepsy, 2012,

    CrossRef

  30. 30
    Andres M. Kanner, Are Antiepileptic Drugs Used in the Treatment of Migraine Associated with an Increased Risk of Suicidality?, Current Pain and Headache Reports, 2011, 15, 3, 164

    CrossRef

  31. 31
    Marco Mula, GABAergic drugs in the treatment of epilepsy: modern or outmoded?, Future Medicinal Chemistry, 2011, 3, 2, 177

    CrossRef

  32. 32
    Sherifa Ahmad Hamed, Psychiatric symptomatologies and disorders related to epilepsy and antiepileptic medications, Expert Opinion on Drug Safety, 2011, 10, 6, 913

    CrossRef

  33. 33
    Marco Mula, Treatment-emergent psychiatric adverse events of antiepileptic drugs in epilepsy: how can we avoid them?, Neuropsychiatry, 2011, 1, 4, 371

    CrossRef

  34. 34
    X. Wen, K.J. Meador, D.W. Loring, S. Eisenschenk, R. Segal, A.G. Hartzema, Is antiepileptic drug use related to depression and suicidal ideation among patients with epilepsy?, Epilepsy & Behavior, 2010, 19, 3, 494

    CrossRef

  35. 35
    Marco Mula, Gail S. Bell, Josemir W. Sander, Suicidality in Epilepsy and Possible Effects of Antiepileptic Drugs, Current Neurology and Neuroscience Reports, 2010, 10, 4, 327

    CrossRef

  36. 36
    Christian Brandt, Heike Elsner, Nora Füratsch, Matthias Hoppe, Esther Nieder, Bernhard Rambeck, Alois Ebner, Theodor W. May, Topiramate overdose: A case report of a patient with extremely high topiramate serum concentrations and nonconvulsive status epilepticus, Epilepsia, 2010, 51, 6
  37. 37
    Scott D. Lane, Joshua L. Gowin, Charles E. Green, Joel L. Steinberg, F. Gerard Moeller, Don R. Cherek, Acute topiramate differentially affects human aggressive responding at low vs. moderate doses in subjects with histories of substance abuse and antisocial behavior, Pharmacology Biochemistry and Behavior, 2009, 92, 2, 357

    CrossRef

  38. 38
    Kent E. Jardemark, Åsa Konradsson, Björn Schilström, Monica M. Marcus, Torgny H. Svensson, Differential effects of topiramate on prefrontal glutamatergic transmission when combined with raclopride or clozapine, Synapse, 2009, 63, 10
  39. 39
    Christian Elger, Peter Halász, Joana Maia, Luis Almeida, Patrício Soares-da-Silva, Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: A randomized, double-blind, placebo-controlled, parallel-group phase III study, Epilepsia, 2009, 50, 3
  40. 40
    Dale C. Hesdorffer, Philip Lee, Health, wealth, and culture as predominant factors in psychosocial morbidity, Epilepsy & Behavior, 2009, 15, 2, S36

    CrossRef

  41. 41
    David E. Friedman, Doris H. Kung, Somchai Laowattana, Joseph S. Kass, Richard A. Hrachovy, Harvey S. Levin, Identifying depression in epilepsy in a busy clinical setting is enhanced with systematic screening, Seizure, 2009, 18, 6, 429

    CrossRef

  42. 42
    S. Lambrey, C. Adam, M. Baulac, S. Dupont, Le syndrome de psychose post-ictale : une entité clinique à connaître, Revue Neurologique, 2009, 165, 2, 155

    CrossRef

  43. 43
    Florent F. Richy, Soutrik Banerjee, Yves Brabant, Sandra Helmers, Levetiracetam extended release and levetiracetam immediate release as adjunctive treatment for partial-onset seizures: An indirect comparison of treatment-emergent adverse events using meta-analytic techniques, Epilepsy & Behavior, 2009, 16, 2, 240

    CrossRef

  44. 44
    Yang-Je Cho, Kyoung Heo, Won-Joo Kim, Sang Hyun Jang, Yo Han Jung, Byoung Seok Ye, Dong Beom Song, Byung In Lee, Long-term efficacy and tolerability of topiramate as add-on therapy in refractory partial epilepsy: An observational study, Epilepsia, 2009, 50, 8
  45. 45
    Norman A. Poole, Bridget K. MacDonald, Niruj Agrawal, Rapid onset of florid psychotic symptoms during video-EEG telemetry: Undetected complex partial status?, Epilepsia, 2009, 50, 1
  46. 46
    Marco Mula, Dale C. Hesdorffer, Michael Trimble, Josemir W. Sander, The role of titration schedule of topiramate for the development of depression in patients with epilepsy, Epilepsia, 2009, 50, 5
  47. 47
    Scott Mintzer, Pharmacology and Therapeutics, 2009,

    CrossRef

  48. 48
    Meyler's Side Effects of Psychiatric Drugs, 2009,

    CrossRef

  49. 49
    GAIL D ANDERSON, JONG M RHO, THE EPILEPSIES 3, 2009,

    CrossRef

  50. 50
    A. Romigi, A. Cervellino, M. G. Marciani, F. Izzi, R. Massoud, M. Corona, F. Torelli, S. Zannino, E. Uasone, F. Placidi, Cognitive and psychiatric effects of topiramate monotherapy in migraine treatment: an open study, European Journal of Neurology, 2008, 15, 2
  51. 51
    John J. Barry, Alan B. Ettinger, Peggy Friel, Frank G. Gilliam, Cynthia L. Harden, Bruce Hermann, Andres M. Kanner, Rochelle Caplan, Sigita Plioplys, Jay Salpekar, David Dunn, Joan Austin, Jana Jones, Consensus statement: The evaluation and treatment of people with epilepsy and affective disorders, Epilepsy & Behavior, 2008, 13, S1

    CrossRef

  52. 52
    Irene García-Morales, Pilar de la Peña Mayor, Andrés M Kanner, Psychiatric Comorbidities in Epilepsy: Identification and Treatment, The Neurologist, 2008, 14, Suppl 1, S15

    CrossRef

  53. 53
    V. Fleury, J. Wayte, M. Kiley, Topiramate-induced delusional parasitosis, Journal of Clinical Neuroscience, 2008, 15, 5, 597

    CrossRef

  54. 54
    Marco Mula, Michael R. Trimble, Josemir W. Sander, Are Psychiatric Adverse Events of Antiepileptic Drugs a Unique Entity? A Study on Topiramate and Levetiracetam, Epilepsia, 2007, 48, 12
  55. 55
    Michael J. Devine, John S. Duncan, Development of psychogenic non-epileptic seizures in response to auditory hallucinations, Seizure, 2007, 16, 8, 717

    CrossRef

  56. 56
    Christian Brandt, Nora Fueratsch, Volker Boehme, Corinna Kramme, Maria Pieridou, Antonia Villagran, Friedrich Woermann, Bernd Pohlmann-Eden, Development of psychosis in patients with epilepsy treated with lamotrigine: Report of six cases and review of the literature, Epilepsy & Behavior, 2007, 11, 1, 133

    CrossRef

  57. 57
    Roberto Frau, Marco Orrù, Mauro Fà, Alberto Casti, Mario Manunta, Nicola Fais, Giampaolo Mereu, Gianluigi Gessa, Marco Bortolato, Effects of Topiramate on the Prepulse Inhibition of the Acoustic Startle in Rats, Neuropsychopharmacology, 2007, 32, 2, 320

    CrossRef

  58. 58
    Marco Mula, Josemir W Sander, Negative Effects of Antiepileptic Drugs on Mood in Patients with Epilepsy, Drug Safety, 2007, 30, 7, 555

    CrossRef

  59. 59
    David W. Loring, Susan Marino, Kimford J. Meador, Neuropsychological and Behavioral Effects of Antiepilepsy Drugs, Neuropsychology Review, 2007, 17, 4, 413

    CrossRef

  60. 60
    D. Weintraub, R. Buchsbaum, S.R. Resor, L.J. Hirsch, Psychiatric and behavioral side effects of the newer antiepileptic drugs in adults with epilepsy, Epilepsy & Behavior, 2007, 10, 1, 105

    CrossRef

  61. 61
    Vladimir V Kalinin, Suicidality and Antiepileptic Drugs, Drug Safety, 2007, 30, 2, 123

    CrossRef

  62. 62
    Marco Mula, Stefano Pini, Giovanni B. Cassano, The Role of Anticonvulsant Drugs in Anxiety Disorders, Journal of Clinical Psychopharmacology, 2007, 27, 3, 263

    CrossRef

  63. 63
    Vivien Tang, Julia Warden, Nora Cullen, Eleanor Rutledge, Topiramate in Traumatic Brain Injury, Journal of Head Trauma Rehabilitation, 2007, 22, 6, 409

    CrossRef

  64. 64
    Frank G. Gilliam, Juan M. Santos, Adverse psychiatric effects of antiepileptic drugs, Epilepsy Research, 2006, 68, 1, 67

    CrossRef

  65. 65
    Bettina Schmitz, Effects of Antiepileptic Drugs on Mood and Behavior, Epilepsia, 2006, 47,
  66. 66
    Jerzy Hildebrand, Neurological complications of cancer chemotherapy, Current Opinion in Oncology, 2006, 18, 4, 321

    CrossRef

  67. 67
    Marco Mula, Andrea E Cavanna, Francesco Monaco, Psychopharmacology of topiramate: from epilepsy to bipolar disorder, Neuropsychiatric Disease and Treatment, 2006, 2, 4, 475

    CrossRef

  68. 68
    E. Ben-Menachem, B. Schmitz, T. Tomson, F. Vajda, Role of valproate across the ages. Treatment of epilepsy in adults, Acta Neurologica Scandinavica, 2006, 114,
  69. 69
    Marco Mula, Josemir W. Sander, Michael R. Trimble, The role of hippocampal sclerosis in antiepileptic drug-related depression in patients with epilepsy: A study on levetiracetam, Seizure, 2006, 15, 6, 405

    CrossRef

  70. 70
    Renzo Guerrini, Lucio Parmeggiani, Topiramate and its clinical applications in epilepsy, Expert Opinion on Pharmacotherapy, 2006, 7, 6, 811

    CrossRef

  71. 71
    Theresa A. Zesiewicz, Archer Tullidge, Jonathan Tidwell, Kelly L. Sullivan, Robert A. Hauser, Topiramate-induced Psychosis in Patients with Essential Tremor, Clinical Neuropharmacology, 2006, 29, 3, 168

    CrossRef

  72. 72
    Amani Eltayb, Marie-Louise G. Wadenberg, Björn Schilström, Torgny H. Svensson, Topiramate augments the antipsychotic-like effect and cortical dopamine output of raclopride, Naunyn-Schmiedeberg's Archives of Pharmacology, 2005, 372, 3, 195

    CrossRef

  73. 73
    Antonio Gil-Nagel, Side Effects of Drugs Annual 28, 2005,

    CrossRef

  74. 74
    Frank MC Besag, Behavioural effects of the newer antiepileptic drugs: an update, Expert Opinion on Drug Safety, 2004, 3, 1, 1

    CrossRef

  75. 75
    Mark Scheepers, Mike Kerr, Epilepsy and behaviour, Current Opinion in Psychiatry, 2004, 17, 3, 203

    CrossRef

  76. 76
    Eric H. Kossoff, Paula L. Pyzik, Improvement in alertness and behavior in children treated with combination topiramate and vagus nerve stimulation, Epilepsy & Behavior, 2004, 5, 2, 256

    CrossRef

  77. 77
    B. de Toffol, Troubles psychopathologiques associés aux épilepsies partielles pharmaco-résistantes, Revue Neurologique, 2004, 160, 288

    CrossRef

  78. 78
    Marco Mula, Francesco Monaco, Michael R Trimble, Use of psychotropic drugs in patients with epilepsy: interactions and seizure risk, Expert Review of Neurotherapeutics, 2004, 4, 6, 953

    CrossRef

  79. 79
    Current awareness in human psychopharmacology, Human Psychopharmacology: Clinical and Experimental, 2003, 18, 7
  80. 80
    Current awareness: Pharmacoepidemiology and drug safety, Pharmacoepidemiology and Drug Safety, 2003, 12, 7
  81. 81
    Elinor Ben-Menachem, Levetiracetam: treatment in epilepsy, Expert Opinion on Pharmacotherapy, 2003, 4, 11, 2079

    CrossRef

  82. 82
    Orrin Devinsky, Psychiatric comorbidity in patients with epilepsy: implications for diagnosis and treatment, Epilepsy & Behavior, 2003, 4, 2

    CrossRef

  83. 83
    Marco Mula, Michael R. Trimble, The importance of being seizure free: topiramate and psychopathology in epilepsy, Epilepsy & Behavior, 2003, 4, 4, 430

    CrossRef

  84. 84
    Marco Mula, Michael R. Trimble, Josemir W. A. S. Sander, The Role of Hippocampal Sclerosis in Topiramate-related Depression and Cognitive Deficits in People with Epilepsy, Epilepsia, 2003, 44, 12
  85. 85
    Further Reading,
  86. 86
    J. Helen Cross, Catherine J. Riney, Topiramate,